Merck Completes Cidara Acquisition to Strengthen Antiviral Pipeline
RAHWAY, New Jersey | January 7, 2026 — Merck has completed its acquisition of Cidara Therapeutics, marking a significant...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
RAHWAY, New Jersey | January 7, 2026 — Merck has completed its acquisition of Cidara Therapeutics, marking a significant...
BRISBANE, California | January 7, 2026 — CareDx and 10x Genomics have announced the launch of ImmuneScape™, a multiomics...
October 14, 2025 | Dallas, TX & Aurora, CO — Verily, UCHealth, the University of Colorado Anschutz, and RefinedScience...
